Skip to main content
. 2022 Feb 13;4(5):479–487. doi: 10.1016/j.cjco.2022.02.002

Figure 4.

Figure 4

Patient satisfaction with noninvasive rejection surveillance screening by blood test, compared with that for invasive endomyocardial biopsy (EMB; n = 29).